Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

Detalles Bibliográficos
Autores principales: Cornely, Oliver A., Duarte, Rafael F., Haider, Shariq, Chandrasekar, Pranatharthi, Helfgott, David, Jiménez, Javier López, Candoni, Anna, Raad, Issam, Laverdiere, Michel, Langston, Amelia, Kartsonis, Nicholas, Van Iersel, Marlou, Connelly, Nancy, Waskin, Hetty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Errata
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297299/
https://www.ncbi.nlm.nih.gov/pubmed/26960721
http://dx.doi.org/10.1093/jac/dkw079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297299/
https://www.ncbi.nlm.nih.gov/pubmed/26960721
http://dx.doi.org/10.1093/jac/dkw079

Ejemplares similares